Skip to main content
Equibles
MASS logo

MASS · 908 Devices Inc. · Metrics

Track MASS — free

Use MASS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MASS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.80 +0.29 (+2.52%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$475.75M
Shares
41.33M
Volume · Oct 21 570.31K Avg daily vol (3M) 422.78K

MASS metrics

85 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.80
Market cap
$475.75M

Price action

20 metrics
Price change (1W)
-4.8%
Price change (30D)
+5.8%
Price change (3M)
+56.6%
Price change (6M)
+58.5%
Price change (YTD)
+119.2%
Price change (1Y)
+28.0%
Trailing year
Price change (5Y)
-65.9%
52-week high
$12.80
52-week low
$5.09
Change from 52-week high
-10.1%
Change from 52-week low
+126.1%
Annualized volatility
61.4%
Annualized volatility (3M)
56.9%
Beta
1.5
RSI (14D)
51.1
Price vs SMA 50
+5.3%
Price vs SMA 200
+42.0%
Avg volume (3M)
418,836
Relative volume
0.9
Average dollar volume
$4.33M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
41.33M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
6.2×
reciprocal yield 16.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
7.8×
reciprocal yield 12.8%
P / book
3.8
reciprocal yield 26.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
319.1
reciprocal yield 0.3%
Earnings yield
-7.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.8×
reciprocal yield 56.3%
EV / revenue historical average (5Y)
3.0×
reciprocal yield 33.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
52.2%
Operating margin
-64.0%
Trailing 12 months
Net margin
-57.0%
Gross profit (TTM)
$31.73M
Operating profit (TTM)
−$38.93M
Net income (TTM)
−$34.66M
Trailing 12 months
Diluted EPS (TTM)
$-0.96
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.66
Gross profit per diluted share (TTM)
$0.86
Operating profit per diluted share (TTM)
$-1.06
EBITDA per diluted share (TTM)
$-0.93
Net income per diluted share (TTM)
$-0.94
Operating cash flow per diluted share (TTM)
$0.04
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.39
Stock compensation per diluted share (TTM)
$0.27
Book value per share
$3.96

Growth

11 metrics
Revenue growth YoY
+23.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$60.84M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.2%
Year over year · more shares
Revenue CAGR (3Y)
+6.2%
Revenue CAGR (5Y)
+15.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-27.3%
Return on assets
-17.5%
Debt / equity
0.0
Current ratio
2.7
EBITDA (TTM)
−$34.23M
Free cash flow (TTM)
—
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$101.53M
Latest balance sheet
Cash & equivalents
$63.02M
Total assets
$197.54M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.49M
Capital expenditures (TTM)
$876,000
R&D (TTM)
$14.41M
SG&A (TTM)
$38.98M
Stock compensation (TTM)
$9.86M
R&D / revenue
23.7%
Stock compensation / revenue
16.2%

Ownership (13F)

9 metrics
13F filers
111
13F filer change QoQ
-1
Institutional ownership
68.1%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
47.3%
Private-fund adviser ownership
46.9%
Active holders' share change QoQ
-0.1%
Holder tenure
10.4
Price vs estimated holder cost
+26.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.3%

Short interest

3 metrics
Short interest
6.6%
Latest settlement · 6.5 days to cover
Days to cover
6.5d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.24M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1555279 CUSIP 65443P102 13F (30d) 13 filings 13 filers Visit website Investor relations